Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
Tenecteplase: Thrombolytic of Choice in Stroke?The EXTEND-IA TNK trial suggesting better outcomes with tenecteplase than alteplase in the treatment of acute ischemic stroke
has now been published in the New England Journal of Medicine.
Medscape Medical News, April 26, 2018
FDA OKs Tolvaptan for Rapidly Progressing Rare Kidney DiseaseBecause of the risks for serious liver injury, tolvaptan is available only through a restricted distribution program supported
by a risk evaluation and mitigation strategy program approved by the FDA.
CMS to Recast 'Meaningful Use' Data Reporting RulesMedicare officials also are using the update of an annual payment to compel hospitals to put their standard charges on the
Internet and to address price of costly CAR T cancer treatment.
Beware of the Agreeable, Noncompliant PatientMany physicians are caught off guard when they face a malpractice lawsuit from a seemingly agreeable patient whom they have known for years. Is there any way to prevent this from happening?
Eric J. Topol, MDDirector, Scripps Translational Science Institute; Chief Academic Officer, Scripps Health; Professor of Genomics, The Scripps Research Institute, La Jolla, California
